Polymorphism in C-C Chemokine Receptor 5 (CCR5) increases susceptibility to Lofgren's syndrome and alters receptor expression as well as functional response

被引：0
|
作者：
Karakaya, Bekir [1 ]
Van Moorsel, C. H. M. [1 ]
Veltkamp, M. [1 ]
Benschop, C. [1 ]
Kazemier, K. M. [2 ]
Van der Helm-Van Mil, A. H. M. [3 ]
Huizinga, T. W. J. [3 ]
Grutters, J. C. [1 ]
Rijkers, G. T. [4 ]
机构：
[1] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Nieuwegein, Netherlands
[2] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[4] Univ Coll Roosevelt, Dept Sci, Middelburg, Netherlands
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Sarcoidosis; Genetics; Inflammation;
D O I：
10.1183/13993003.congress-2021.OA3980
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA3980
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The expression of the chemokine receptor CCR5 in psoriasis and the results of a randomized placebo controlled trial with a CCR5 receptor inhibitor
    de Groot, M.
    Teunissen, M. B.
    Picavet, D., I
    Arreaza, M. G.
    Simon, J. S.
    Kraan, M.
    Bos, J. D.
    de Rie, M. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 59 - 59
  • [22] The expression of the chemokine receptor CCR5 in psoriasis and the results of a randomized placebo controlled trial with a CCR5 receptor inhibitor
    de Groot, M.
    Picavet, D. I.
    de Rie, M. A.
    Teunissen, M. B.
    Bos, J. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S39 - S39
  • [23] The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
    Torretta, Simone
    Colombo, Giorgia
    Travelli, Cristina
    Boumya, Sara
    Lim, Dmitry
    Genazzani, Armando A.
    Grolla, Ambra A.
    CELLS, 2020, 9 (02)
  • [24] Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
    Gómez-Reino, JJ
    Pablos, JL
    Carreira, PE
    Santiago, B
    Serrano, L
    Vicario, JL
    Balsa, A
    Figueroa, M
    De Juan, MD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (05): : 989 - 992
  • [25] Absence of the C-C chemokine receptor-5 polymorphism in a Korean population
    Kim, Jeong Joong
    Min, Jung Youl
    Lee, Jae Hoon
    KOREAN JOURNAL OF GENETICS, 2006, 28 (04): : 369 - 373
  • [26] C-C chemokine receptor 5 polymorphism in inflammatory bowel disease.
    Simmons, JD
    Marshall, SE
    Welsh, KI
    Jewell, DP
    GASTROENTEROLOGY, 1999, 116 (04) : A821 - A821
  • [27] Expression of the C-C chemokine receptor 5 in human kidney diseases
    Segerer, S
    Mack, M
    Regele, H
    Kerjaschki, D
    Schlöndorff, D
    KIDNEY INTERNATIONAL, 1999, 56 (01) : 52 - 64
  • [28] Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression
    Li, C
    Lu, SC
    Hsieh, PS
    Huang, YH
    Huang, HI
    Ying, TH
    Shieh, B
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2005, 32 (02) : 99 - 106
  • [29] Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages
    Bosco, MC
    Reffo, G
    Puppo, M
    Varesio, L
    CELLULAR IMMUNOLOGY, 2004, 228 (01) : 1 - 7
  • [30] Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection
    Laurence, J
    GASTROENTEROLOGY, 2002, 122 (07) : 2069 - 2072
12345